| Dr Weiguo Victor Li, MD, MPH | |
|
625 Clark Ave Ste 17a, King Of Prussia, PA 19406-1438 | |
| (610) 768-7168 | |
| (610) 768-7169 |
| Full Name | Dr Weiguo Victor Li |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 29 Years |
| Location | 625 Clark Ave Ste 17a, King Of Prussia, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295931038 | NPI | - | NPPES |
| 101963965 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD432040 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hospital Of Univ Of Pennsylvania | Philadelphia, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Weiguo Li, Llc | 0749363414 | 2 |
News Archive
BioTuesday Publishing Corporation, a division of Kilmer Lucas Inc., announced today its launch of an independent business and investing news blog, BioTuesday.ca, that will focus on exciting companies and technologies in the Canadian healthcare sector.
As Massachusetts' state legislators put the finishing touches on a major health care cost-control bill, there is still one big question: How much could it save? A recent report claims employers and employees could see between $8 billion and $34.5 billion in savings over nine years.
IRX Therapeutics, a developer of novel immunomodulators to treat cancer and viral diseases, today announced that it has established a strategic collaboration with Japan's National Cancer Research Center (NCRC) to evaluate next-generation peptide-based cancer vaccines. Clinical research will be conducted at NCRC. IRX Therapeutics will provide its proprietary IRX-2 immunomodulatory regimen, clinical trial design and technical support. This is the first collaboration of its kind between the NCRC and a U.S.-based biotechnology firm.
New guidelines for on-field treatment and emergency transport of young athletes with suspected neck injuries should recommend keeping both helmet and shoulder pads on for initial stabilization and transport, followed by removal of both, once the patient is in a controlled setting, according to new research released today at the 2008 American Orthopaedic Society for Sports Medicine Specialty Day at The Moscone Center.
A new database will collect information from clinicians about COVID-19-related neurological symptoms, complications, and outcomes as well as COVID-19 effects on pre-existing neurological conditions.
› Verified 8 days ago
| Entity Name | Weiguo Li, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083801773 PECOS PAC ID: 0749363414 Enrollment ID: O20080219000333 |
News Archive
BioTuesday Publishing Corporation, a division of Kilmer Lucas Inc., announced today its launch of an independent business and investing news blog, BioTuesday.ca, that will focus on exciting companies and technologies in the Canadian healthcare sector.
As Massachusetts' state legislators put the finishing touches on a major health care cost-control bill, there is still one big question: How much could it save? A recent report claims employers and employees could see between $8 billion and $34.5 billion in savings over nine years.
IRX Therapeutics, a developer of novel immunomodulators to treat cancer and viral diseases, today announced that it has established a strategic collaboration with Japan's National Cancer Research Center (NCRC) to evaluate next-generation peptide-based cancer vaccines. Clinical research will be conducted at NCRC. IRX Therapeutics will provide its proprietary IRX-2 immunomodulatory regimen, clinical trial design and technical support. This is the first collaboration of its kind between the NCRC and a U.S.-based biotechnology firm.
New guidelines for on-field treatment and emergency transport of young athletes with suspected neck injuries should recommend keeping both helmet and shoulder pads on for initial stabilization and transport, followed by removal of both, once the patient is in a controlled setting, according to new research released today at the 2008 American Orthopaedic Society for Sports Medicine Specialty Day at The Moscone Center.
A new database will collect information from clinicians about COVID-19-related neurological symptoms, complications, and outcomes as well as COVID-19 effects on pre-existing neurological conditions.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Weiguo Victor Li, MD, MPH 625 Clark Ave Ste 17a, King Of Prussia, PA 19406-1438 Ph: (610) 768-7168 | Dr Weiguo Victor Li, MD, MPH 625 Clark Ave Ste 17a, King Of Prussia, PA 19406-1438 Ph: (610) 768-7168 |
News Archive
BioTuesday Publishing Corporation, a division of Kilmer Lucas Inc., announced today its launch of an independent business and investing news blog, BioTuesday.ca, that will focus on exciting companies and technologies in the Canadian healthcare sector.
As Massachusetts' state legislators put the finishing touches on a major health care cost-control bill, there is still one big question: How much could it save? A recent report claims employers and employees could see between $8 billion and $34.5 billion in savings over nine years.
IRX Therapeutics, a developer of novel immunomodulators to treat cancer and viral diseases, today announced that it has established a strategic collaboration with Japan's National Cancer Research Center (NCRC) to evaluate next-generation peptide-based cancer vaccines. Clinical research will be conducted at NCRC. IRX Therapeutics will provide its proprietary IRX-2 immunomodulatory regimen, clinical trial design and technical support. This is the first collaboration of its kind between the NCRC and a U.S.-based biotechnology firm.
New guidelines for on-field treatment and emergency transport of young athletes with suspected neck injuries should recommend keeping both helmet and shoulder pads on for initial stabilization and transport, followed by removal of both, once the patient is in a controlled setting, according to new research released today at the 2008 American Orthopaedic Society for Sports Medicine Specialty Day at The Moscone Center.
A new database will collect information from clinicians about COVID-19-related neurological symptoms, complications, and outcomes as well as COVID-19 effects on pre-existing neurological conditions.
› Verified 8 days ago
Dr. Sharon Marie O'brien, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 625 Clark Ave Ste 13, King Of Prussia, PA 19406 Phone: 610-265-8566 Fax: 610-878-2620 | |
Dr. Jeanvickey Lusk, M.d., M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 315 Gypsy Lane, King Of Prussia, PA 19406 Phone: 215-200-8447 | |
Charissa Gardner Myers, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 700 S Henderson Rd Ste 306, King Of Prussia, PA 19406 Phone: 610-265-0726 Fax: 601-265-3132 | |
Kimberly A Richardson, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 210 Mall Blvd, Ste 102, King Of Prussia, PA 19406 Phone: 610-265-0726 Fax: 610-265-3132 | |
Andrew A Badulak, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 700 S Henderson Rd, Ste 308c, King Of Prussia, PA 19406 Phone: 610-337-3111 Fax: 610-337-3506 | |
P. Michael Glowacki, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 210 Mall Blvd, Ste 102, King Of Prussia, PA 19406 Phone: 610-265-0726 Fax: 610-265-3132 |